Skip to main content
!
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.

Scientists trace severe COVID-19 to faulty genes and autoimmune condition

The findings explain why some people are so vulnerable to the infection, and suggest new avenues for treatment.

When the city locked down, RockEDU moved the lab bench to the kitchen table

With input from participating students and scientists who volunteer with RockEDU, a blended Summer Science Research Program for high-school students was developed. The result was a modified SSRP curriculum with five experiential research tracks, complete with lab supply kits that were mailed to students’ homes.

Attention needs more attention 

Scientists long believed they knew precisely which nooks of the brain control our ability for selective attention. Now, new findings are redrawing the maps.

>

How dividing cells avoid setting off false virus alarms

A new molecular structure explains how cells hold an alarm-triggering protein captive during cell division, preventing cells from targeting their own DNA.

Microbes in the gut may influence metabolism

A growing number of studies find that microbes in the gut directly influence biological processes from bowel movements to behavior. New research reveals how they impact levels of glucose in the blood.

Return of the cytonaut 

The lysosome is having a moment. More than 60 years after this bubble-shaped cell structure was first discovered, scientists have found that it is key to our ability to metabolize iron, and a potential target for new cancer drugs.

Bulgari Corporation to support Rockefeller's COVID-19 research and women scientists

Over the next three years, the fund will augment the university's wide-ranging research initiatives aimed at alleviating the COVID-19 pandemic, and also support the its women scientists in their training and careers.

Heritable genome editing technology is not yet ready for clinical use, concludes an international commission co-chaired by President Lifton

A range of scientific and medical issues have yet to be addressed, the committee determined, and many ethical, moral, and societal concerns remain.

>

Scientists uncover antiviral protein that blocks coronavirus infection

New research identifies a protein that blocks infection by SARS-CoV-2, the coronavirus that causes COVID-19, along with several other types. The findings could inform treatment strategies and help us better prepare for future outbreaks.

How mechanical forces nudge tumors toward malignancy

Researchers studying two forms of skin cancer identified a long-overlooked factor determining why some tumors are more likely to metastasize than others: the physical properties of the tissue in which the cancer originates. The findings might set the stage for new ways to monitor and treat the diseases in the future.

Recent Awards and Honors

Junyue Cao

Junyue Cao wins Science & SciLifeLab Grand Prize For Young Scientists

November 19, 2020

Cao is recognized for his work using single-cell genomic methods to enable developmental mapping of entire organisms, described in an essay published in Science.
LLuciano Marraffini portrait

Luciano Marraffini awarded Max Planck-Humboldt Medal

October 14, 2020

Marraffini receives the award for his achievements studying CRISPR-Cas, a bacterial immune mechanism whose discovery led to modern gene-editing tools.
More awards and honors

Rockefeller in the News

The New York Times

Laboratory studies from Michel Nussenzweig and others of mutations circulating in South Africa suggest they may dodge some of the body’s immune responses.

The Wall Street Journal

Researchers are working on new antibody drugs that can be given with quick jabs in the arm, similar to flu shots. They would enable patients to get treated quickly after being diagnosed with Covid-19, said Michel C. Nussenzweig, an immunologist and professor at Rockefeller University in New York.

Nature News

Evidence from Jean-Laurent Casanova and others is growing that self-attacking ‘autoantibodies’ could be the key to understanding some of the worst cases of SARS-CoV-2 infection.

Seek magazine

Rockefeller’s flagship publication is interested not just in scientific results, but in the people, ideas, and conversations that ignite discovery. The latest issue takes us inside the response to the pandemic, where scientists are using every tool in the 21st century playbook to transform COVID-19 into a manageable disease. Also: Mosquito menace, The brain inside your gut, and Addiction then and now.


From this issue

 


Subscribe to Rockefeller Science News

Did you know Rockefeller has a monthly science newsletter? Subscribe now to stay on top of the latest discoveries, news updates, and science highlights from Rockefeller’s laboratories and researchers.